Long-term Results of Corneal Cross-linking for Terrien's Marginal Degeneration.

PURPOSE To report the long-term clinical outcomes of a patient with Terrien's marginal degeneration who underwent successful peripheral corneal cross-linking (CXL) to arrest progression. METHODS Clinical assessment included uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), corneal topography, anterior segment optical coherence tomography, ultrasonic pachymetry, corneal hysteresis, and corneal resistance factor. Eccentric epithelium-off CXL was performed in both eyes after limbal conjunctival resection. Following the Dresden protocol, fluence irradiation was set at 5.4 J/cm2, using 3 mW/cm2 for a total exposure time of 30 minutes. RESULTS Nine years of postoperative follow-up showed significant bilateral improvement in visual acuity, refraction, and corneal topography with no signs of progression of Terrien's marginal degeneration. In the right eye, UDVA improved from 0.05 to 0.3 decimal and CDVA from 0.8 to 1.2 decimal, cylinder was reduced from -14.00 to -3.00 diopters (D), simulated keratometry improved from 10.50 to 3.70 D, and the thinnest point on pachymetry remained almost unchanged (from 483 to 469 μm). In the left eye, UDVA improved from 0.1 to 0.2 decimal and CDVA remained unchanged at 1.2 decimal, cylinder was reduced from -6.00 to -2.75 D, simulated keratometry improved from 5.60 to 3.30 D, and the thinnest point on pachymetry remained stable at 486 μm. CONCLUSIONS Eccentric peripheral CXL can be a safe, noninvasive alternative therapeutic approach for the management of Terrien's marginal degeneration with peripheral thinning. [J Refract Surg. 2018;34(6):424-429.].

[1]  Aditi Dubey,et al.  Management of advanced corneal ectasias , 2015, British Journal of Ophthalmology.

[2]  F. Hafezi,et al.  Corneal collagen cross-linking for ectasia after LASIK and photorefractive keratectomy: long-term results. , 2013, Ophthalmology.

[3]  G. Conrad,et al.  Resistance of corneal RFUVA–cross-linked collagens and small leucine-rich proteoglycans to degradation by matrix metalloproteinases. , 2013, Investigative ophthalmology & visual science.

[4]  A. Quantock,et al.  The Effect of Riboflavin/UVA Collagen Cross-linking Therapy on the Structure and Hydrodynamic Behaviour of the Ungulate and Rabbit Corneal Stroma , 2013, PloS one.

[5]  C. Mazzotta,et al.  Long-term results of riboflavin ultraviolet a corneal collagen cross-linking for keratoconus in Italy: the Siena eye cross study. , 2010, American journal of ophthalmology.

[6]  Theo Seiler,et al.  Complication and failure rates after corneal crosslinking , 2009, Journal of cataract and refractive surgery.

[7]  Eberhard Spoerl,et al.  Collagen crosslinking with riboflavin and ultraviolet‐A light in keratoconus: Long‐term results , 2008, Journal of cataract and refractive surgery.

[8]  Ting Huang,et al.  Evaluation of different types of lamellar keratoplasty for treatment of peripheral corneal perforation , 2008, Graefe's Archive for Clinical and Experimental Ophthalmology.

[9]  Theo Seiler,et al.  Increased resistance of crosslinked cornea against enzymatic digestion , 2004, Current eye research.

[10]  T. Gray,et al.  Alcohol debridement of the corneal epithelium in PRK and LASEK: an electron microscopic study. , 2003, Investigative ophthalmology & visual science.

[11]  E. Spörl,et al.  Bestrahlung der Hornhaut mit UV-Licht und Riboflavingabe als neuer Behandlungsversuch bei einschmelzenden Hornhautprozessen, erste Ergebnisse bei vier Patienten1 2 3 , 2000 .

[12]  M. Ashenhurst,et al.  Corneal hydrops in Terrien's marginal degeneration: an unusual complication. , 1987, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.

[13]  G. Beauchamp Terrien's marginal corneal degeneration. , 1982, Journal of pediatric ophthalmology and strabismus.